BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18989492)

  • 1. Transudates in malignancy: still a role for pleural fluid.
    Gonlugur TE; Gonlugur U
    Ann Acad Med Singap; 2008 Sep; 37(9):760-3. PubMed ID: 18989492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologically proved malignant pleural effusions: distribution of transudates and exudates.
    Assi Z; Caruso JL; Herndon J; Patz EF
    Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Testing on Pleural Fluid Samples.
    Oh S; Ronaghi R; Cai G
    Semin Respir Crit Care Med; 2019 Jun; 40(3):340-346. PubMed ID: 31525809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
    Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
    Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
    Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
    Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the value of fibronectin as a tumour marker in malignant pleural mesothelioma.
    Emri S; Ustündağ Y; Budak T; Karakoca Y; Ozdemir O
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):335-8. PubMed ID: 9401361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
    Froudarakis ME; Plojoux J; Kaspi E; Anevlavis S; Laroumagne S; Karpathiou G; Roca E; Adler D; Dutau H; Astoul P
    Clin Respir J; 2018 Mar; 12(3):1011-1016. PubMed ID: 28245530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.
    Elmas H; Biancosino C; Önal B; Schmitt F; Buyucek S; Nordholt G; Sauter G; Welker L
    Adv Exp Med Biol; 2022; 1374():51-62. PubMed ID: 35147931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
    Segal A; Sterrett GF; Frost FA; Shilkin KB; Olsen NJ; Musk AW; Nowak AK; Robinson BW; Creaney J
    Pathology; 2013 Jan; 45(1):44-8. PubMed ID: 23222247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
    Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
    Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathology of pleural mesotheliomas.
    Nguyen GK
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S68-81. PubMed ID: 11996173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration of malignant mesothelioma with unusual morphologic features: a case report.
    Kapur U; Wojcik EM
    Diagn Cytopathol; 2007 Mar; 35(3):174-8. PubMed ID: 17415923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
    Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
    BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
    Paintal A; Raparia K; Zakowski MF; Nayar R
    Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the clinical significance of transudative malignant pleural effusion?
    Ryu JS; Ryu ST; Kim YS; Cho JH; Lee HL
    Korean J Intern Med; 2003 Dec; 18(4):230-3. PubMed ID: 14717231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positivity of pleural fluid cytologic examination in transudative pleural effusions.
    Foresti V; Scolari N; Villa A
    Chest; 1998 Dec; 114(6):1798-9. PubMed ID: 9872236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.